Farmlands Shareholders Challenge AgriZeroNZ Investment
Farmers opposing rural trader Farmlands’ investment in AgriZeroNZ are warning the co-operative board not to brush away their concerns.
A US-based company developing a vaccine to reduce methane emissions in cattle has received another capital injection from New Zealand’s agriculture sector.
ArkeaBio is considered one of the leaders in the global race to develop a methane vaccine for livestock and it’s offering could benefit New Zealand’s pasture-based farmers.
AgriZeroNZ, a joint venture between the NZ government and agribusinesses, has followed up its initial investment of $10 million last year with a $6m injection last month.
AgriZeroNZ chief executive Wayne McNee says its follow-on investment recognises ArkeaBio’s progress and the immense potential.
“A vaccine has the potential to reduce agricultural emissions at scale by providing a low cost, high-impact solution for a range of farming systems,” says McNee.
“As an export-reliant country, New Zealand farms need to stay ahead of the curve and step up to the challenge of meeting the global demand for climate action.
“We’re pleased to continue backing ArkeaBio as part of our efforts to provide Kiwi farmers with a toolkit of options to reduce emissions and retain access to high-value markets.”
Since AgriZeroNZ’s initial in 2024, ArkeaBio has made significant scientific progress, says McNee.
The company has been working with researchers at Texas A&M University, with trials showing ArkeaBio’s vaccine successfully reduces methane emissions from cattle. The vaccine works by stimulating a cow’s immune system to produce natural antibodies that neutralise methane-producing microbes in the rumen (a part of the stomach).
Newly appointed chief executive Frank Wooten says the team has advanced to a second- generation vaccine formulation, focusing on increasing commercial viability and animal productivity.
“With our vaccine advancing toward realworld deployment, we’re focused on delivering measurable emissions reductions, as well as tangible value to farmers and producers worldwide.”
Wooten says the company is aiming to produce a vaccine that’s effective for 6 months or more and is on track to achieve its target methane reduction of 20%.
He says the new funding from AgriZeroNZ will allow ArkeaBio to continue refining its vaccine and carry out further animal trials, including its first in New Zealand.
“We’re prioritising making our vaccine available to New Zealand farmers and are hoping to launch the first product in 2028,” he says.
During visits to New Zealand, ArkeaBio has met with ministers and a range of AgriZeroNZ’s investors, including the Ministry for Primary Industries, to discuss its path to market.
“New Zealand’s special combination of public- private collaboration, and track record of agricultural innovation make it an ideal place for us to launch,” says Wooten.
“Trialling our vaccine in New Zealand is an exciting next step to prove its effectiveness and safety in the pastoral farming conditions. We’re excited to have AgriZeroNZ’s support to bring this solution to farmers.”
During the nesting season, from September to December, industrious starlings can quickly build nests in the darker areas behind tractor and vehicle, usually close to hot engines, typically resulting in localised damage or in some cases complete write-offs.
The meat processing industry is much more collegial than it was in the past and is now more focused on common goals.
With the last couple of months having seen some potential tractor purchases put on hold with the impending election and continued input cost rises, year-to-date figures, ending September, has seen deliveries up around 5% over the same period in 2025, with a total of 2026 units.
Beef+Lamb New Zealand is calling for nominations for director roles in the Northern South Island and Northern North Island electoral districts.
Fonterra chief executive, Richard Allen says being resilient has helped the dairy industry overcome extreme volatility in recent years.
The head of the Ministry for Primary Industries (MPI) trade and international relations group says New Zealand is well-positioned to secure trade access and compete internationally as the world becomes more complicated, demanding and uncertain.